Radiography
Volume 14, Issue 1 , Pages 8-16 , February 2008

Menstrual variation of breast volume and T2 relaxation times in cyclical mastalgia

  • Zainab Hussain

      Affiliations

    • Department of Medical Imaging, University of Liverpool, Johnstone Building, Brownlow Hill, P.O. Box 147, Liverpool, Merseyside L69 3GB, UK
    • Magnetic Resonance and Image Analysis Research Centre, University of Liverpool, Johnstone Building, Brownlow Hill, P.O. Box 147, Liverpool, Merseyside L69 3GB, UK
    • Corresponding Author InformationCorresponding author. Department of Medical Imaging, University of Liverpool, Johnstone Building, Brownlow Hill, P.O. Box 147, Liverpool, Merseyside L69 3GB, UK. Tel.: +44 151 794 5763; fax: +44 151 794 5776.
  • ,
  • Jonathan Brooks

      Affiliations

    • Magnetic Resonance and Image Analysis Research Centre, University of Liverpool, Johnstone Building, Brownlow Hill, P.O. Box 147, Liverpool, Merseyside L69 3GB, UK
    • Department of Human Anatomy and Genetics, University of Oxford, Oxford, UK
  • ,
  • Dave Percy

      Affiliations

    • Centre for Operational Research and Applied Statistics, University of Salford, Salford, Greater Manchester M5 4WT, UK

Received 16 December 2005 ,Accepted 28 July 2006.

References 

  1. Dalton K. The premenstrual syndrome and progesterone therapy. Oxford: William Heinemann Medical Books; 1985;
  2. Reiman SP, Seabold PS. Correlation of X-ray pictures with histology in certain breast lesions. Am J Cancer. 1933;1:34–41
  3. Ingelby H. Changes in breast volume in a group of normal young women. Bull Int Assoc Museums. 1949;29:877–892
  4. Milligan D, Drife JO, Short RV. Changes in breast volume during normal menstrual cycle and after oral contraceptives. Br Med J. 1975;4(5995):494–496
  5. Malini S, Smith EO, Goldzieher JW. Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Obstet Gynaecol. 1985;669(4):538–541
  6. Fowler PA, Casey CE, Cameron GG, Foster MA, Knight CH. Cyclic changes in composition and volume of the breast during the menstrual cycle measured by magnetic resonance imaging. Br J Obstet Gynaecol. 1990;97(7):595–602
  7. Graham SJ, Stanchev PL, Lloyd-Smith JOA, Bronskill MJ, Piewes DB. Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging. 1995;5(6):696–701
  8. Hussain Z, Roberts N, Whitehouse GH, Garcia-Finana M, Percy D. Estimation of breast volume and its variation during the menstrual cycle. BJR. 1999;72(855):236–245
  9. Dowle CS. Breast pain classification, aetiology and management. Aust NZ J Surg. 1987;57(7):423–428
  10. Hamed H, Fentiman IS. Benign breast disease. Int J Clin Pract. 2001;55(7):461–464
  11. Millet AV, Dirbas FM. Clinical management of breast pain. Obstet Gynaecol Survey. 2002;57(7):451–461
  12. Khan SA, Apkarian AV. The characteristics of cyclical and non-cyclical mastalgia: a propepective study using a modified pain Questionnaire. Breast Cancer Res Treat. 2002;75(2):147–157
  13. Hughes LE, Mansel RE, Webster DJT. Breast pain and nodularity: benign disorders and diseases of the breast. London: Bailliere Tindall; 1989;
  14. Padden DL. Mastalgia: evaluation and management. Nurse Prac Forum. 2000;11(4):213–218
  15. Preece PE, Mansel RE, Bolton PM, Hughes LM, Baum M, Gravelle IH. Clinical syndromes of mastalgia. Lancet. 1976;2(7987):670–673
  16. Ayers J, Gidwani G. The luteal breast and hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia. Fertil Steril. 1983;40(6):779–784
  17. England PC, Skinner LG, Cottrell KM, Selwood RA. Serum oestradiol-17β in women with benign and malignant breast disease. Br J Cancer. 1974;30(6):571–576
  18. Kumar S, Mansel R, Scanlon M. Altered response of prolactin, lutenising hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br J Surg. 1984;71(11):870–873
  19. Kumar S, Mansel R, Wilson D. Daily salivary progesterone levels in cyclical mastalgia patients and their controls. Br J Surg. 1986;73(4):260–263
  20. Malarkey WB, Schroeder LL, Stevens VC, James AG, Lanese RR. Twenty-four hour pre-operative profiles in women with benign and malignant breast disease. Can Res. 1977;37(12):4655–4659
  21. Sitruk-Ware R, Sterkers N, Mowiszowicz I, Mauvais-Jarvis P. Inadequate corpus luteum function in women with benign breast diseases. Clin Endocrinol Metab. 1977;44(2):771–774
  22. Echochard R, Marret H, Rabilloud M, Boehringer H, Mathieu C, Guerin J. Gonadotropin level abnormalities in women with cyclic mastalgia. Eur J of Obstet Gynaecol Reprod Biol. 2001;94(1):92–96
  23. O'Brien PM, Abukail IE. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol. 1999;180(1):18–23
  24. Sheffer BD, Price TE, Loughry WZ, Bolyard BL, Morek WM, Varga RS. Validity and reliability of biostereometric measurement of the human female breast. Ann Biomed Engin. 1998;14(1):1–14
  25. Kataryia RN, Forrest APM, Gravelle IH. Breast volumes in cancer of the breast. Br J Cancer. 1974;29(3):270–273
  26. Scutt D, Lancaster GA, Manning JT. Breast asymmetry and predisposition to breast cancer. Breast Cancer Res. 2006;8(2):R14
  27. Jack CR, Sharborough FW, Cascino GD, Hirshorn KA, O‘Brien PC, Marsh WR. MRI-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol. 1992;31(2):138–146
  28. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain. 1992;115(4):1001–1005
  29. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol. 1993;50(9):949–954
  30. Laakso MP, Soininen H, Partanen K, Helkala EL, Hartikainen P, Vainio P, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI -based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect. 1995;9(1):73–86
  31. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, et al. A comprehensive study of grey matter loss in patients with Alzheimer's disease using optimised voxel-based morphometry. Neuroimage. 2003;18(4):895–907
  32. Critchley HD, Good CD, Ashburner J, Frackowiak RS, Mathias CJ, Dolan RJ. Changes in cerebral morphology consequent to peripheral autonomic denervation. Neuroimage. 2003;18(4):908–916
  33. Light K, Roberts N, Whitehouse GH, Edwards RHT. Unbiased and efficient estimation of bladder volume with MR imaging. J Magn Reson Imaging. 1995;5(1):33–41
  34. Roberts N, Cruz-Orive LM, Reid N, Brodie D, Bourne M, Edwards RHT. Unbiased estimation of human body composition using the Cavalieri method and magnetic resonance imaging. J Microsc. 1993;171(3):239–253
  35. Roberts N, Garden AS, Cruz-Orive LM, Whitehouse GH, Edwards RHT. Estimation of fetal volume by MRI and stereology. Br J Radiol. 1994;67(803):1067–1077
  36. Payne GS, Dowsett M, Leach MO. Hormone-dependent metabolic changes in the normal breast monitored non-invasively by 31P magnetic resonance (MR) spectroscopy. Breast. 1994;3(1):20–23
  37. Dzendrowskyj TE, Noyszewski EA, Beers J, Bolinger L. Lipid composition changes in normal breast throughout the menstrual cycle. MAGMA. 1997;5(2):105–110
  38. Glunde K, Ackerstaff E, Natarajan K, Artemov D, Bhujwalla ZM. Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin. Magn Reson Med. 2002;48(5):819–825
  39. Griffiths JR, Tate AR, Howe FA, Stubbs M. Magnetic Resonance Spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma. Eur J Cancer. 2002;38(16):2085–2093
  40. Sabatier J, Gilard V, Malet-Martino M, Ranjeva JP, Terral C, Breil S, et al. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol. 1999;34(3):230–235
  41. Schwarz AJ, Maisey NR, Collins DJ, Cunninghaam D, Huddart R, Leach MO. Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours. Br J Radiol. 2002;203(900):959–966
  42. Gribbestad IS, Singstad TE, Nilsen G, Fjosne HE, Engan T, Haugen OA, et al. In vivo 1H MRS of normal breast and breast tumours using a dedicated double breast coil. J Magn Reson Imag. 1998;8(6):1191–1197
  43. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7cm3) resolution. Radiology. 1996;198(3):795–805
  44. Dean KI, Majurin ML, Komu M. Relaxation times of normal breast tissue: changes with age and variations during the menstrual cycle. Acta Radiol. 1994;35(3):258–261
  45. Martin B, El Yousef SJ. Transverse relaxation times in MR imaging of the normal breast during menstrual cycle. J Comput Assist Tomog. 1986;10(6):924–927
  46. Nelson RT, Pretorius DH, Schiffer LM. Menstrual variation of normal breast NMR relaxation parameters. J Comput Assist Tomogr. 1985;9(5):875–879
  47. Berensen HJC. Specific interaction of water with polymers. In:  Franks F editors. Water a comprehensive treatise. New York: Plenum Press; 1975;
  48. Lerski RA, de Certaines JD. Performance assessment and quality control in MRI by Eurospin test objects and protocols. Magn Reson Imaging. 1993;11(6):817–833
  49. Mueller-Schimpfle M, Ohmenhauser O, Stoll P, Dietz K, Laussen C. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203(1):145–149
  50. Taylor DG, Bore CF. A review of the magnetic resonance response of biological tissue and its applicability to the diagnosis of cancer by nuclear magnetic resonance radiology. J Comput Tomogr. 1981;5(2):122–133
  51. Barnes D, McDonald WI, Landon DN, Johnson G. The characterisation of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain. 1988;111(1):83–94
  52. Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Yoshizaki K. Proton nuclear magnetic resonance studies of brain oedema. J Neurosurg. 1982;56(6):747–752
  53. American College of Obstetricians and Gynaecologists . Non-malignant conditions of the breast: ACOG Technical Bulletin. Int J Gynaecol Obstet. 1992;39(1):53–58
  54. Wolfe JN. Breast parencyhmal patterns: prevalent and incident carcinomas. A study of breast parenchyma by mammography in normal women and those and those with benign or malignant disease. Radiology. 1979;31(1):267–268
  55. Wolfe JN. Breast parenchymal patterns and their relationship to risk for developing carcinoma. Radiol Clin North Am. 1976;21(1):127–136
  56. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach M, Hawkes D. Non-rigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging. 1999;18(8):712–721
  57. Calmon G, Roberts N. Automatic measurement of changes in brain volume on consecutive 3D MR images by segmentation propogation. Magn Reson Imaging. 2000;18(4):439–453
  58. Helm G, Piringer A. Magnetization transfer of water T(2) relaxation components human brain: implications for T(2)-based segmentation of spectroscopic volumes. Magn Reson Imaging. 2001;19(6):803–811
  59. Partridge C, McKinnon GC, Henry RG, Hylton NM. Variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imag. 2001;14(4):433–438

PII: S1078-8174(06)00086-1

doi: 10.1016/j.radi.2006.07.003

Radiography
Volume 14, Issue 1 , Pages 8-16 , February 2008